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A B S T R A C T
Objective: French validation of the Foot Function Index (FFI), self-questionnaire designed to evaluate
rheumatoid foot according to 3 domains: pain, disability and activity restriction.
Methods: The ﬁrst step consisted of translation/back translation and cultural adaptation according to the
validated methodology. The second stage was a prospective validation on 53 patients with rheumatoid
arthritis who ﬁlled out the FFI. The following data were collected: pain (Visual Analog Scale), disability
(Health Assessment Questionnaire) and activity restrictions (McMaster Toronto Arthritis questionnaire).
A test/retest procedure was performed 15 days later. The statistical analyses focused on acceptability,
internal consistency (Cronbach’s alpha and Principal Component Analysis), test-retest reproducibility
(concordance coefﬁcients), external validity (correlation coefﬁcients) and responsiveness to change.
Results: The FFI-F is a culturally acceptable version for French patients with rheumatoid arthritis. The
Cronbach’s alpha ranged from 0.85 to 0.97. Reproducibility was correct (correlation coefﬁcients > 0.56).
External validity and responsiveness to change were good.
Conclusion: The use of a rigorous methodology allowed the validation of the FFI in the French language
(FFI-F). This tool can be used in routine practice and clinical research for evaluating the rheumatoid foot.
The FFI-F could be used in other pathologies with foot-related functional impairments.
 2015 Elsevier Masson SAS. All rights reserved.
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According to a 2010 epidemiological study [1] focusing on the
prevalence of foot pain in rheumatoid arthritis (RA) and its care
management, 35.4% of patients indicated that their feet was the
ﬁrst symptomatic site of RA. In all, 90.3% of responders reported
foot pain for more than one day since the beginning of their
pathology and 69.2% of them experienced foot pain during one day
in the past month. In responders, 64% of patients had previously
seen a podiatrist and only 54.2 of patients had plantar orthosis.
The French High Health Authority (HAS) [2] published
recommendations regarding the non-pharmacologic care manage-
ment of patients with RA. Podiatric follow-up and the prescription
of adapted footwear and plantar orthosis are recommended. In§ This article has been published in collaboration with HAS. We thank the French
High Health Authority to allow us to reproduce this text.
* Corresponding author.
E-mail address: ecoudeyre@chu-clermontferrand.fr (E. Coudeyre).
http://dx.doi.org/10.1016/j.rehab.2015.07.003
1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.order to be able to evaluate the impact of the various therapeutic
modalities, it is necessary to have a validated assessment tool.
Several tools have been described in the literature to evaluate the
rheumatoid foot. We focused mainly on the Foot Function Index (FFI)
published by Budiman-Mak et al. in 1991 [3,4]. This questionnaire
includes 23 items, scored from 1 to 10 using the Visual Analog Scale
(VAS) and divided into three subscales: ‘‘pain’’ (score up to 90),
‘‘function’’ (score up to 90) and ‘‘activity limitation’’ (score up to 50).
The total maximum score is 230. The FFI is designed to measure both
current state, deﬁned as the past week before taking the test, and
change in status.
The FFI psychometric properties conﬁrmed the relevance of
validating it in the French language. In the original article [5],
internal consistency evaluated by Cronbach’s alpha was reported at
0.9556 for the total score. Test-retest reliability evaluated by an
Intraclass Correlation Coefﬁcient (ICC) was also good at 0.87
(0.79–0.92) for the total score. A literature review dating from
2008 [3] allowed the confrontation of several tools to assess the
rheumatoid foot and compare their psychometric properties.
Among the different questionnaires evaluated, the FFI emerged as
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ness to change was correct. A revised version of the FFI was also
validated [6].
The use of FFI [7–12] in clinical practice makes it a reference
tool. It is most often used as an evaluation tool for the rheumatoid
foot and it is the questionnaire most used by AOFAS members
[13]. Helliwell [14] used the FFI as a reference to develop a new
evaluation scale to assess foot function in RA.
Furthermore, several validated translated versions of the FFI are
now available in the Netherlands [15], Germany [13] and China
[16].
Overall, we choose the FFI because of its validated use in
assessing the rheumatoid foot, its solid psychometric properties
and its simple administration, with the objective to provide
physicians with a reference tool for French patients.
The objective of this work is the validation of the FFI in the
French language.
2. Methods
2.1. Translation of the FFI and cultural adaptation
The translation of the FFI in French abided by the literature
guidelines [17–20]. Step 1: translations of the FFI into French
performed by two independent French native translators. Step 2:
synthesis by both translators and an observer based on the two
previous translations. Step 3: double translation/back translation
in English of the French version of the FFI by two native English
speakers, without any medical background and blinded from the
original English version. Step 4: elaboration by a committee of
three experts of a pre-ﬁnal version. Step 5: validation test of the
pre-ﬁnal version on 10 patients.
2.2. French version of the Foot Function Index (FFI-F)
The validated FFI-F is a self-questionnaire made of 23 items
scored from 0 to 10 on a numeric scale and spread out in three
subscales: pain (out of 90), function (out of 90) and activity
limitation (out of 50).
Looking at all the various published translations of the
FFI [13,15,16], we noticed that most of these questionnaires
included 18 items and not 23 as in the original questionnaire.
This is due to the fact that the third domain related to activity
limitations was taken off in several versions, because its
reproducibility was deemed too low. We chose not to change
the initial questionnaire by keeping the 23 items in order to be
consistent in comparing our statistical results with those of the
original questionnaire.
2.3. Patient cohort and validation procedure
The prospective validation was conducted on patients with RA
who ﬁlled out the FFI-F questionnaire. These patients came from
the Physical Medicine and Rehabilitation (PM&R) and rheumatol-
ogy consultations as well as rheumatology hospitalization.
Patients had validated RA according to the American College of
Rheumatology (ACR) criteria [21] with or without foot affections
and were able to understand and read French. The number of
patients to be included was set to a minimum of 50, following the
recommendations published by Terween et al. [22] and in
accordance with our recruitment abilities. Furthermore, the
following data were collected: foot-related history and recent
disease activity score (DAS) 28-C-reactive protein (CRP) and
erythrocyte sedimentation rate (ESR). For each patient, the
maximum walking perimeter was collected. During the consulta-
tion, the time needed to walk 10 m and 200 m was recorded. Eachfoot was examined: collecting deformations, painful joints, range
of motion, and testing of ankle and foot muscles.
In order to evaluate the external validity of the questionnaire
for each of the successive domains, each patient, aside from the FFI-
F, also ﬁlled out a VAS for the pain on the day of the consultation
and the previous week, the Health Assessment Questionnaire
(HAQ) [23] and the main foot disability using the McMaster
Toronto Arthritis (MACTAR) questionnaire [24].
The latter is also used to compensate for the limited evaluation
of activity limitation in the third subscale of the FFI-F. This tool was
initially validated and used to assess RA-related activity limita-
tions. In our case, the question asked was: which is the main
disability related to your rheumatoid feet?
The retest was performed at D15.
2.4. Statistical considerations
In addition to the usual descriptive statistical analyses, the
following psychometric properties of the scale were explored:
 acceptability: data quality was deemed acceptable if less than 5%
of data were missing. The range (minimum and maximum),
mean (and associated standard deviation SD) and median, ﬂoor
and ceiling thresholds (for both, the maximum accepted as 15%),
and asymmetry in scores’ distribution (skewness and kurtosis
measures, limits: from -1 to +1) were analyzed;
 internal consistency was evaluated with the Cronbach a
coefﬁcient (accepted minimal value: 0.70), the inter-item
correlation coefﬁcient ( 0.30) and the overlap (correlation
between an item and its dimension,  0.30) (data not shown
here). Internal consistency was also determined by the
correlation between the domains making up the scale (standard,
0.30 to 0.70) [25]. Construct validity of the FFI-F was explored
using a principal component analysis (PCA). A factorial analysis
(principal component analysis and varimax rotation) was
conducted in order to determine the multi-dimension structure
of the scale. PCA consists in replacing a family of variables by
new variables with maximum variation, not correlated two by
two and which are linear combinations of the original variables.
These new variables, called principal. These new variables,
called principal components, deﬁne factorial planes serving as a
base for a graph representation of the initial variables. Thus, it is
an approach designed to synthesize the data to study and
visualize the correlations between variables (in this case FFI
items) in order to explore the links between items and study
their potential redundancy. The ﬁnal number of factors selected,
the part of data to be kept and the screen plot of eigenvalues
were determined according to the eigenvalue-one criterion
(Kaiser criterion);
 reproducibility: the intraclass correlation coefﬁcient (random-
effects model ICC) and the Lin’s Concordance Correlation
Coefﬁcient (CCC) were computed to determine the test-retest
reliability. ICC and CCC values  0.70 were deemed satisfactory;
 regarding external consistency, relationships between the
questionnaire score and the other measures (HAQ, MACTAR
and VAS) were evaluated via the correlation coefﬁcient
(Pearson’s or Spearman’s according to the distribution of the
parameters studied, P > 0.50);
 accuracy: for each domain, the standard error of the mean (SEM)
was computed as such SEM = SD  H (1-ICCtest-retest). It is
admitted that good accuracy is equivalent to SEM  1/2 (SD).
Furthermore, the valued associated to the SDD (smallest
detectable difference) for each domain was calculated from
the reproducibility study allowing to evidence, for the 3 subscales
of the FFI, an estimation of the variability of the measure and thus
of the error;
C. Pourtier-Piotte et al. / Annals of Physical and Rehabilitation Medicine 58 (2015) 276–282278 following the exhaustive analysis of the published studies
[26–29], it seems that no method, related to the sensitivity of
a measure, has been validated in the scientiﬁc world. In this
study, the responsiveness to change was evaluated by paired
samples’ tests (Student’s t-test or Wilcoxon signed-rank test, if
the conditions of the t-test were not respected) in order to study
the evolution of the parameters associated to the HAG, and VAS
(day and week) and the FFI domains on the study population.
In this study, the responsiveness to change was evaluated by
paired samples’ tests (Student’s t-test or Wilcoxon signed-rank
test, if the conditions of the t-test were not respected) in order to
study the evolution of the parameters associated to the HAG, and
VAS (day and week) and the FFI domains on the study population.
2.5. Ethics
The protocol, the information sheet as well as the case report
form were submitted to the Ethics Committee of the Clinical
Investigation Centers of the Inner region Rhoˆne Alpes Auvergne.
The Ethics Committee gave its approval on 12/15/2011. A signed
written consent form was collected from patients before study
inclusion. The study was conducted according to good clinical
practices and the declaration of Helsinki.
3. Results
3.1. Translation and cultural adaptation
Cultural adaptations were necessary. The main one concerned
the evaluation of the gait perimeter. The notion of ‘‘blocks’’ was not
used in France to evaluate distance. After research, 200 m was
equivalent to one block thus we adapted the translation ‘‘four
blocks’’ by using 800m. FFI-F was read by 10 patients who did not
ﬁnd it necessary to change that version.
3.2. Descriptive analysis
Prospective validation was conducted on 53 patients with RA
who ﬁlled out the FFI-F. The cohort included 39 women and
14 men aged 17 to 78 years. Median disease progression time was
14 years (interquartile range IQR 5–23). Thirty-four patients were
unemployed. Only 14 patients had seen a podiatrist before the
beginning of the disease. Thirty-four had foot orthosis and 7 had
custom-made therapeutic footwear. Two patients had previous
foot surgery. The total of the scores obtained for each questionnaire
is listed in Table 1.Table 1
Baseline data.
Age (years); m (SD) 60 ( 12)
Female, nb (%) 39 (73.6)
Pathology duration (years), median
[interquartile interval]
14 [5–23]
Working patients: n (%) 19 (35.8)
Podiatric care, n (%) 13 (24.5)
Foot orthosis, n (%) 34 (64.1)
Custom-made therapeutic shoes, n (%) 7 (13.2)
Foot surgery, n 2
DAS28 ESR, m (SD) 2.65 ( 1.5)
DAS28 CRP, m (SD) 2.75 ( 1.6)
200 m walking test (seconds); m (SD) 141 ( 27.3)
10 m walking test (meters/seconds); m (SD) 1.36 ( 0.46)
Maximal walking distance (meters); m (SD) 2873 ( 3323)
VAS pain on the day of inclusion; m (SD) 34.4 ( 26.8)
VAS pain in the past last week; m (SD) 35.3 ( 25.6)
HAQ; m (SD) 1.22 ( 0.93)
MACTAR; m (SD) 5.28 ( 3.04)
m: mean; SD: standard deviation; n: number.3.3. Acceptability
The quality and acceptability of the FFI-F data are detailed in
Table 2.
The time needed to complete the FFI-F was under 10 minutes
for the entire population. The only recurring difﬁculty seems to be
to ﬁll-out the questionnaires pertaining to the VAS, the use of this
tool remains complicated for older patients.
3.3.1. Principal component analysis
The FFI-F construct validity was assessed with the principal
component analysis (PCA) allowing the identiﬁcation of 4 factors
(Fig. 1) explaining 85% of the initial variance. The ﬁrst component
was associated with the intensity of the responses (all contribu-
tions were positive and in the same order of magnitude) regardless
of the dimension studied and thus could not help differentiate
the 3 domains studied by the scale. Component 2 characterized
items 1 to 9 corresponding to pain assessment (strong negative
contributions) items 19 to 23 were used to evaluate activity
limitation (strong positive contributions). Items 22 and 23 were
the only ones well represented in the third component. Component
4 differentiated items 10 to 18 related to disability (strong negative
contributions) from other items. The ﬁrst dimension of the PCA
was related to 66% of the initial information, the second dimension
was related to 9% of the information, meaning 75% for the ﬁrst
factorial axis.
3.4. Internal consistency
Cronbach’s alpha was at 0.97 for FFI-F Pain, 0.97 for FFI-F
function and 0.85 for FFI-F activity limitation. The ITCC ranged
from 0.71 to 0.95 according to the items. These results are listed in
Table 4.
The internal consistency analysis was completed by the
calculation of the correlation between the domains making up
the scale. The inter-item correlation and the item-dimension
correlation were excellent except for the last domain (from 0.57 to
0.96 for the 1st domain; from 0.69 to 0.99 for the 2nd domain and
from 0.28 to 0.89 for the 3rd domain) and mainly pertaining to the
last question. Regarding correlations between domains we found a
Pearson’s r of 0.94 for the correlation between total FFI-F and FFI-F
pain; 0.97 for the correlation FFI-F total and FFI-F function; 0.84 for
the correlation between FFI-F total and activity limitation; 0.86 for
the correlation between FFI-F pain and FFI-F function; 0.67 for the
correlation between FFI-F pain and FFI-F function and 0.78 for the
correlation between FFI-F function and activity limitation.
3.5. Reproducibility
Lin concordance coefﬁcient was: 0.90 for total FFI-F, 0.87 for
FFI-F pain, 0.89 for FFI-F function and ﬁnally 0.56 for FFI-F activity
limitation. The numbers obtained for ICC were similar. Exhaustive
results for each item are listed in Table 3.
3.6. External validity
External validity was evaluated by calculating a correlation
coefﬁcient between FFI-F and other questionnaires (Table 4). Total
FFI-F was well correlated to VAS, HAQ and MACTAR (correlation
coefﬁcient > 0.5). It is important to note that FFI-F activity
limitation was not as well correlated to VAS and HAQ and was
poorly correlated to MACTAR (correlation coefﬁcient of 0.39).
Walking speed (10 m and 200 m tests) was not correlated to FFI-F.
There was a reverse correlation between gait perimeter and FFI-F.
Regarding the inﬂammatory status of the RA, its correlation to FFI-F
varied.
Table 2
Quality and acceptability of FFI-F data.
n Mean Standard deviation Skewness Kurtosis Median Min Max Floor effect
%
Ceiling effect
%
Total 49 99.36 61.49 0.23 1.77 115 0 208 8.26 2.04
Pain 53 43.45 25.45 0.28 1.50 46.29 0 90 9.43 1.89
Function 51 43.22 27.24 0.33 1.72 50 0 88 9.80 1.96
Activity limitation 51 12.87 12.35 0.69 2.22 9 0 41 17.65 1.96
SD: standard deviation; Min: minimum value; Max: maximum value.
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Data regarding accuracy study are presented in Table 5
(including ICC and SEM). SEM (standard error of the mean) was
lower than SD/2 for the total FFI score and the pain and function
domains. For the activity limitation domain, SEM was at 8.2 and
SD/2 at 6.2.
3.8. Sensibility to change
The evolution of parameters associated with HAQ, and VAS (day
and week) and FFI dimension were then analyzed on the study
population. Thus, HAQ varied from 1.22 (0.93) to 1.28 (0.88) (delta:
0.06 [0.18–0.06], P = 0.30). VAS scales varied from 34.1 (26.9) to
35.8 (23.9) for VAS day (delta: 1.74 [7.20–3.72], P = 0.53) and
34.39 (25.71) to 37.08 (26.54) for VAS week (delta: 2.69 [7.39–
2.01], P = 0.25). FFI domains did not vary in a statistically signiﬁcant
manner between the two different evaluation times: pain (3.46
[6.97–0.04], P = 0.06), function (0.70 [4.40–3.00], P = 0.70) and
activity limitation (2.40 [5.91–1.11], P = 0.17).
4. Discussion
Originally, the FFI questionnaire was one of the ﬁrst validated
questionnaires to evaluate the rheumatoid foot through differentFig. 1. Principal comdimensions. It is a self-questionnaire with a short administration
time making it easy to use in daily practice. It is easy to ﬁll-out. Its
validity of use makes it a reference tool as validated by many
studies that used FFI as well as its translation in several languages
[13,15,16]. During the translation stage, only one cultural
adaptation was necessary regarding distance evaluation repre-
sented in the English version by ‘‘four blocks’’. We then chose to
use a numeric scale from 0 to 10 with numbers to circle (to score
each item) to improve patients’ comprehension and facilitate data
analysis.
According to the statistical analysis performed, FFI-F is a
validated tool. Its metrological properties are correct and its
acceptability is satisfactory. Of note, there is a limited ceiling effect
for the third domain activity limitation (ceiling effect at
17.65% > 15%) in accordance with the numerous negative answers
from the patients interviewed.
The Principal Component Analysis (PCA) shows an excellent
repartition of the domains. The PCA was considered in order to
explore the internal structure of the FFI. The ﬁrst dimension can
characterize patients with a high global FFI score (domains
positively correlated to one another, with a moderate to strong
correlation). The second component can help differentiate the
3 domains of the FFI, the items from a same domain were more
closely related together than with items from other domains.
FFI-F has an excellent internal consistency as validated by
Cronbach’s alpha close to 1. It is not as good for the third domain,ponent analysis.
Table 3
Internal consistency and test-retest reproducibility.
(Internal
consistency a)
ITCC
Lin concordance coefﬁcient
(95% IC)
Total NA 0.90 (0.85–0.95)
Pain (0.97) 0.87 (0.80–0.93)
Q 1 0.86 0.69 (0.54–0.83)
Q 2 0.89 0.80 (0.70–0.90)
Q 3 0.93 0.88 (0.82–0.94)
Q 4 0.93 0.85 (0.78–0.93)
Q 5 0.95 0.86 (0.79–0.93)
Q 6 0.94 0.85 (0.78–0.93)
Q 7 0.86 0.81 (0.69–0.92)
Q 8 0.87 0.80 (0.68–0.92)
Q 9 0.95 0.80 (0.70–0.90)
Function (0.97) 0.89 (0.82–0.95)
Q 10 0.88 0.83 (0.75–0.92)
Q 11 0.93 0.82 (0.73–0.91)
Q 12 0.89 0.75 (0.63–0.87)
Q 13 0.94 0.84 (0.75–0.92)
Q 14 0.95 0.85 (0.77–0.93)
Q 15 0.89 0.85 (0.77–0.93)
Q 16 0.91 0.87 (0.81–0.94)
Q 17 0.92 0.87 (0.81–0.94)
Q 18 0.93 0.80 (0.70–0.90)
Activity limitation (0.85) 0.56 (0.37–0.75)
Q 19 0.89 0.60 (0.42–0.77)
Q 20 0.77 0.56 (0.38–0.74)
Q 21 0.82 0.67 (0.52–0.83)
Q 22 0.78 0.44 (0.22–0.65)a
Q 23 0.71 0.52 (0.31–0.72)b
ICC: Intraclass Correlation Coefﬁcient.
a Positive answer = 0 or > 0: test-retest reproducibility kappa: 0.53 (P < 0.001).
b Positive answer = 0 or > 0: test-retest reproducibility kappa: 0.52 (P < 0.001).
Table 5
Accuracy.
SD SD/2 ICC SEMa SDDb
Total 61.5 30.75 0.90 19.4 53.8
Pain 25.5 12.75 0.87 9.2 25.5
Function 27.2 13.6 0.89 9.0 24.9
Activity limitation 12.4 6.2 0.56 8.2 22.7
a SEM = SD  H (1-ICCtest-retest). Good accuracy is considered if SEM  1/2 (SD).
b SDD = 1.96  H2  SEM.
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and the negative results were often collected for these items.
Correlation coefﬁcient between these different domains are good,
the weakest was the correlation coefﬁcient FFI-F pain and FFI-F
activity limitation. This element can be explained by the fact that
disability in RA is not only related to pain. The test-retest
reproducibility is good since the concordance correlation coefﬁ-
cient is excellent. Regarding external validity, the correlation VAS
pain and total FFI is correct. However, we note a weaker correlation
with the third domain, which can be explained by the fact that pain
is not the sole etiology in activity limitations. We ﬁnd also a good
correlation between total FFI-F and HAQ. We note that patients
with a low HAQ sometimes have a high FFI-F > 80/230. FFI-F could
underline a foot-related disability not previously evidenced by the
HAQ (questionnaire with no foot-speciﬁc item). Finally, FFI-F was
well correlated to the MACTAR and this, regardless of the item
positioned as the main disability on the 3 answers.
The study’s cohort sample was quite varied as shown by the
descriptive analysis. The age range was wide and women wereTable 4
Convergent validity: correlation (Pearson or Spearman if necessary).
Total Pain Function Activity
limitation
VAS Pain upon inclusion 0.73 0.73 0.68 0.57
VAS pain in the past week 0.69 0.71 0.62 0.55
HAQ 0.73 0.66 0.75 0.59
MACTAR 0.71 0.71 0.64 0.39
MACTAR (1st item) 0.70 0.73 0.64 0.37
DAS28 ESR 0.46 0.45 0.54 0.16*
DAS28 CRP 0.54 0.54 0.59 0.21*
200 m test 0.39 0.34 0.42 0.23*
10 m test 0.40 0.29* 0.43 0.40
Gait perimeter 0.48 0.45 0.48 0.38
* P > 0.05.predominant. The results of the FFI, VAS foot pain and HAQ covered
a wide range of individuals. Mean total FFI-F was 99.36/230 with a
minimum at 0/230 and a maximum at 208/230. Those were
patients with moderate pain since the mean VAS was 34.43
(26.78). In the original article [5], the mean total FFI was only
28.09 with a maximum value at 77.67 reﬂect data from a population
where patients were less bothered by their feet than our sample. This
element reinforces the weight of our results since our sample was
even larger than the one from the original validation study. The FFI-F
enables to evaluate in a satisfactory manner the rheumatoid foot,
regardless of the disease progression. We also ﬁnd similar values for
the internal consistency and test-retest (ICC), external validity is good
in both cases, without being able to precisely compare the results
since the reference tools used were different. Furthermore, the
different statistical results obtained in our study are highly similar to
the other validations of FFI translations [13,15,16].
No correlation between the FFI-F and walking tests was
highlighted. The 10 m and 200 m tests, objective gait speed
measures, evaluate gait more in terms of performance, which
probably does not reﬂect the functional gait of patients with RA.
The absence of correlation between FFI and the 10 m walking test
was already validated [30], authors attributed it to patients’
progressive adaptation to their disease. However, the gait
perimeter is conversely correlated to FFI-F. Gait perimeter,
measured on a declaratory mode, is a relevant tool to assess the
real gait capacities of patients with RA.
It is admitted that good accuracy is equivalent to SEM  1/2
(SD) thus total FFI, FFI pain, FFI function have a good accuracy
which is not the case for the last domain of the questionnaire, since
it is mixed and thus more inﬂuenced by other elements than foot
pain.
If we focus on study limitations, one could wonder if the
population studied included extreme clinical types (linked to
recruitment), which could have been a source of bias. In fact, the
wide range of answers can validate the diversity of this population,
thus avoiding for the study to focus only on one category of
patients followed at the hospital.
Furthermore, FFI was criticized because of its lack of analysis
pertaining to activity limitations [31] This questionnaire, made of
3 subscales, explores thoroughly the impairments while focusing
on pain evaluation, function – thanks to the evaluation of the
consequences of gait impairments and going up and down the
stairs for example – but it is less relevant for evaluating activity
limitations. The third domain is a partial vision of activity
limitations, which includes several dimensions: the impact on
work, psychological status, social status, and activities of daily
living. We could argue the choice of FFI versus the FFI-R [6]
published at a later date. The latter is a revised version of the FFI
designed to better account for the different domains of the
International Classiﬁcation of Functioning, Disability and Health
(CIF), especially activity limitation while asking questions related
to psychosocial consequences. Its use is limited by its length since
it includes more than 50 items. There is a shorter version of the
FFI-R but its statistical analysis is being debated. Nowadays, the FFI
seems more adapted, even if the third domain explores, in a limited
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a correct correlation between FFI-F and MACTAR and the activity
limitation domain of the FFI. This can be explained by the fact that
FFI-F is a generic tool compared to the MACTAR which is a speciﬁc
one. A speciﬁc foot-adapted MACTAR might be the right tool to use
to evaluate activity limitation in addition to the FFI-F. Using both
tools concomitantly, we could have an evaluation tool for the
rheumatoid foot that would cover a larger range of concepts and
quality of life.
Finally, as it was underlined in the validation of the initial scale,
the internal consistency study and PCA show a possible
redundancy of questions since the results are so high, validated
by the excellent correlations between the 3 domains, which are
meant to explore different correlations. Along that line, our results
are similar to those of the original validation of the initial study,
with also the same drawbacks.
This study leads to several perspectives regarding this
evaluation tool for the rheumatoid foot. This questionnaire could
be used in clinical practice during consultations for foot-related RA
and in clinical trials.
This type of cultural adaptation could help develop cross-
sectional studies to evaluate targeted therapeutics for the
rheumatoid foot.
5. Conclusion
This study led to a culturally acceptable version of the Foot
Function Index-French (FFI-F) evaluation tool that can be used
in daily practice or research, for French-speaking patients
with rheumatoid arthritis affecting their feet. A rigorous
methodology enabled to validate the translation of the FFI in
terms of internal consistency and external validity. Results
from the different statistical analyses are for the most part
comparable with those of the original study and the other
translations published.
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Appendix 1. French translation of the FFI
Traduction franc¸aise de l’Indice fonctionnel du pied (FFI-F)
Ce questionnaire a e´te´ conc¸u aﬁn de donner a` votre me´decin des
informations sur la fac¸on dont votre douleur aux pieds modiﬁe
votre vie quotidienne. Merci de bien vouloir re´pondre aux
questions suivantes. Nous souhaitons que pour chacune des
questions suivantes, vous e´valuiez sur une e´chelle de 0 a` 10 ce qui
de´crit le mieux l’e´tat de vos pieds durant la semaine dernie`re.
Lisez chaque question s’il vous plaıˆt et entourez un chiffre
correspondant de 0 a` 10.
E´chelle de la douleur : Quelle e´tait l’intensite´ de votre
douleur aux pieds ? :
De 0 (aucune douleur) a` 10 (pire douleur imaginable)
Q1 Lorsqu’elle e´tait la pire ?
Q2 Le matin au re´veil ?
Q3 Lorsque vous marchiez pieds nus ?
Q4 Lorsque vous restiez debout pieds nus ?Q5 Lorsque vous marchiez avec des chaussures ?
Q6 Lorsque vous restiez debout avec des chaussures ?
Q7 Lorsque vous marchiez avec des semelles orthope´diques ?
Q8 Lorsque vous restiez debout avec des semelles
orthope´diques ?
Q9 A` la ﬁn de la journe´e ?
E´chelle de fonction : Quel degre´ de difﬁculte´ aviez-vous
pour ? :
De 0 (aucune difﬁculte´) a` 10 (si difﬁcile qu’impossible seul ou
ne´cessite de l’aide)
Q10 Marcher lorsque vous e´tiez au domicile ?
Q11 Marcher dehors ?
Q12 Marcher 800 m ?
Q13 Monter les escaliers ?
Q14 Descendre les escaliers ?
Q15 Rester sur la pointe des pieds ?
Q16 Vous lever d’une chaise ?
Q17 Monter sur un trottoir ?
Q18 Marcher vite ?
E´chelle des activite´s limite´es: Dans quelle mesure e´tiez vous
contraint de ? :
De 0 (pas de contrainte) a` 10 (contrainte maximale ou telle que
ne´cessite de l’aide)
Q19 Rester toute la journe´e chez vous a` cause de vos pieds ?
Q20 Rester allonge´ a` cause de vos pieds ?
Q21 Limiter vos activite´s a` cause de vos pieds ?
Q22 Utiliser une aide de marche (canne, de´ambulateur,
be´quilles. . .) a` l’inte´rieur ?
Q23 Utiliser une aide de marche (canne, de´ambulateur,
be´quilles. . .) a` l’exte´rieur ?
A` remplir par le me´decin
Score: /230 a` rapporter a` 100
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